Markku Laakso
University of Eastern Finland
2 papers in the Anchorcite directory, published between 1998 and 2006, cited 11,148 times in total.
ORCID profileResearch topics
- Diabetes, Cardiovascular Risks, and Lipoproteins · 1 paper
- Diabetes Treatment and Management · 1 paper
- Acute Myocardial Infarction Research · 1 paper
- Adipose Tissue and Metabolism · 1 paper
- Sirtuins and Resveratrol in Medicine · 1 paper
- Metabolism, Diabetes, and Cancer · 1 paper
Frequent co-authors
- Steven M. Haffner · 1 paper
- Seppo Lehto · 1 paper
- Tapani Rönnemaa · 1 paper
- Kalevi Pyörälà · 1 paper
- Marie Lagouge · 1 paper
- Carmen Argmann · 1 paper
- Zachary Gerhart‐Hines · 1 paper
- Hamid Méziane · 1 paper
Papers
- Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial InfarctionNew England Journal of Medicine · 1998 · 7,026 citations
BACKGROUND: Type 2 (non-insulin-dependent) diabetes is associated with a marked increase in the risk of coronary heart disease. It has been debated whether patients with diabetes who have not had myocardial infarctions should be treated as aggressively for cardiovascular risk…
- Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1αCell · 2006 · 4,122 citations
Diminished mitochondrial oxidative phosphorylation and aerobic capacity are associated with reduced longevity. We tested whether resveratrol (RSV), which is known to extend lifespan, impacts mitochondrial function and metabolic homeostasis. Treatment of mice with RSV significantly increased their aerobic capacity, as…
Metadata from OpenAlex (CC0).